Human intervention study of deer bone powder for evaluating the joint function in mild osteoarthritis

Human intervention study of deer bone powder for evaluating the joint function in mild osteoarthritis: a randomized, double-blind, controlled study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001567

Enrollment

Registered

2015-07-14

Start date

2015-09-02

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consumption of deer bone powder supplement or placebo (1 tablet a day for 12 weeks, 550mg/tablet of deer bone powder)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agrees to participate and sign in informed consent form. 2) Adults aged over 50 years. 3) Subject who suffers from osteoarthritis. 4) Subject whose Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain score is over 5 point.

Exclusion criteria

Exclusion criteria: 1) Subjects with Kellgren-Lawrence grade 3 or 4 2) Subjects who intakes medication of nonsteroidal anti-inflammatory drug (NSAID) within 1 week prior to the first visit 3) Inflammatory osteoarthritis (increase of ESR or CRP) 4) High obesity (BMI = 30) 5) Other nervous system or lower limb abnormality such as hip joint or foot joint that can disturb gait 6) More than moderate degree of back pain or radiating pain in lower limbs 7) Severe neurological and vascular disorders in lower limbs 8) Hypersensitivity to test materials 9) Participation in another clinical trial within 4 weeks prior to the study 10) Any other disease affecting the results of the study

Design outcomes

Primary

Measure	Time frame
Questionnaire for joint health	—

Secondary

Measure	Time frame
Biomarker in blood and urine;Radiographic assessment	—

Countries

Korea, Republic of

Contacts

Public ContactEunae Kim

Bundang CHA General Hospital

Outcome results